
© Hera Biotech
United States of America
Hera Biotech
- 2025
- Speaker
- Venture
Hera Biotech features MetriDx™ and HeraFem®. MetriDx™ is a non-surgical test for the definitive diagnosis and staging of endometriosis, and HeraFem® is a point-of-care cervical cancer diagnostic device that delivers real-time results.